Supranuclear Palsy, Progressive Clinical Trial
Official title:
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003
The purpose of this study is to evaluate the long-term safety and tolerability of multiple intravenous (IV) infusions of BIIB092 in participants with Progressive Supranuclear Palsy (PSP). The study will also assess the pharmacodynamic (PD) effects of BIIB092 on cerebrospinal fluid (CSF) N-terminal tau, pharmacokinetics (PK), and immunogenicity of BIIB092 in participants with PSP.
This study, previously posted by Bristol-Myers Squibb, has transitioned to Biogen under a licensing agreement. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00368199 -
Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes
|
N/A | |
| Completed |
NCT02132052 -
Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography.
|
||
| Completed |
NCT03076671 -
More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease
|
N/A | |
| Terminated |
NCT03068468 -
Study of BIIB092 in Participants With Progressive Supranuclear Palsy
|
Phase 2 | |
| Recruiting |
NCT04468932 -
Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy
|
N/A | |
| Completed |
NCT04858893 -
Application of Machine Learning Method in Validation of Screening Cognitive Test for Parkinsonisms
|
||
| Recruiting |
NCT00139373 -
Study of the Distractibility Syndrome in Patients With Progressive Supranuclear Palsy
|
Phase 2 |